Company news

Oramed Pharmaceuticals Inc. news in 2020

Oramed Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.

View company

Oramed Reports Positive First in Human Data from Oral Leptin Study

December 22, 2020

Oramed Initiates Phase 2 NASH Trial of Oral Insulin

December 1, 2020

Oramed Initiates Phase 3 Trial of Oral Insulin

November 23, 2020

Nobel Laureate, Oramed SAB member Prof. Avram Hershko and Oramed CSO Dr. Miriam Kidron to be Featured on Biotalknology Webinar "Oral Delivery of Therapeutic Proteins - Oramed Story" on November 18, 2020

November 11, 2020

Oramed to Present at H.C. Wainwright 6th Annual Israel Conference

November 9, 2020

Oramed to Present Phase 2b Oral Insulin Data at American Association of Pharmaceutical Scientists 2020 PharmSci 360 Conference

October 27, 2020

Oramed CEO Nadav Kidron & Premas Biotech to Host Webinar "The Journey of Oral Insulin: Oramed Story" on Wednesday October 28, 2020

October 26, 2020

Oramed Issues Shareholder Update on Pivotal Phase 3 Oral Insulin Studies: Protocols Submitted to FDA

October 15, 2020

Oramed Pharmaceuticals to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting

September 20, 2020

Oramed's Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and Patients

September 14, 2020

Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral Insulin

July 14, 2020

Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin

June 14, 2020

Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June

May 4, 2020

Oramed Patent in Canada Allowed for Oral Delivery of Proteins

April 6, 2020

Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19

March 31, 2020

Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA

March 18, 2020

Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million

February 26, 2020

Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial

February 25, 2020

Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock

February 25, 2020

Oramed to Present at BIO CEO & Investor Conference

February 3, 2020

Oramed Appoints Dr. Julio Rosenstock to Its Scientific Advisory Board

January 29, 2020

Oramed Patent in Europe to be Granted for Oral Delivery of Proteins

January 27, 2020

Oramed Elects Dr. Alexander Fleming to Scientific Advisory Board

January 22, 2020

Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board

January 20, 2020

Decks in 2020